Scopus Eşleşmesi Bulundu
3
Atıf
34
Cilt
625-636
Sayfa
Özet
Cistus laurifolius L., Cistaceae, has long been used for traditional treatments against various skin diseases in Turkey. The study was designed to observe an antiviral effect against anti-HSV-1 activity and to develop an antiviral herbal lip balm. The cytotoxic activities of C. laurifolius extracts and their ability to inhibit cytopathic effect were evaluated by colorimetric XTT test on Vero cells. In the first experiments, crude extracts did not show antiviral activity due to high toxicity. The solid phase extraction, purification, and polyphenolic enrichment methods were applied for EtOH, MeOH, and H2O extracts to reduce the toxicity of the extracts and in this way, high antiviral results were obtained. Polyphenol-enriched fractions of MeOH (SI 431.17) and H2O (SI > 455.37), purified with solid phase extraction, showed high antiviral effects against HSV-1. In vitro, cytotoxicity for polyphenol-enriched of EtOH, MeOH, and H2O from C. laurifolius was investigated on human dermal fibroblast cells to develop herbal lip balm formulations. All fractions had no cytotoxic effect on human dermal fibroblast cells. Herbal lip balm formulations were also developed, and evaluation tests were performed on the herbal lip balm in this study. Twenty-one different phenolic contents in the extracts were dereplicated by HPLC–DAD. The hyperoside (49.37 ± 0.53 mg/g extract), isoquercitrin (48.05 ± 0.74 mg/g extract), rutin (45.84 ± 1.02 mg/g extract), epicatechin (14.83 ± 1.00 mg/g extract), quercetin-3-O-glucopyranoside (13.35 ± 0.16 mg/g extract), catechin (12.80 ± 0.1 mg/g extract), caffeic acid (3.15 ± 0.18 mg/g extract), and apigenin (6.30 ± 0.10 mg/g extract) were determined as the major components present in the polyphenol-enriched fractions of C. laurifolius H2O extract. The results show that the polyphenol-enriched fractions of C. laurifolius extracts have good anti-Herpes simplex virus type-1 activity, and the herbal formulation with antiviral activity has a better option with minimum side effects. Graphical Abstract: (Figure presented.)
Web of Science Eşleşmesi Bulundu
3
WoS Atıf
34
Cilt
Article
Belge Türü
Kaynak: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY
· s. 625-636
Anahtar Kelimeler (WoS)
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 3.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2024 yılı verileri
Revista Brasileira de Farmacognosia
Q2
SJR Quartile
0,366
SJR Skoru
64
H-Index
🔓
Açık Erişim
Kategoriler: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
Alanlar: Pharmacology, Toxicology and Pharmaceutics
Ülke: Brazil
· Springer International Publishing
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
Antiviral formulation
Antioxidants
Herpes simplex virus type-1
HPLC-DAD characterization
Lip treatment
Polyphenols
WoS |
Bir kelimeye tıklayıp ilgili kaynaktaki yayınları görün.
Makale Bilgileri
Dergi
Revista Brasileira de Farmacognosia
ISSN
1981-528X
Yıl
2024
/ 1. ay
Cilt / Sayı
34
Sayfalar
625 – 636
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q4
Teşvik Puanı
0,64
· YÖKSİS Akademik Teşvik
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
7 kişi
Erişim Türü
Basılı+Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Neonatoloji (Çocuk Sağlığı ve Hastalıkları)
YÖKSİS Yazar Kaydı
Yazar Adı
OKUMUŞ NURULLAH,ERDOĞMUŞ SEVİM FEYZA,DOĞAN HASAN HÜSEYİN,ERDAL ALTINTAŞ ÖZLEM,ÇELİK SEFA,DUMAN RÜSTEM,ÜNLÜ ÜMMÜHAN
YÖKSİS ID
8389264